THE EXECUTIVE COMMITTEE | CURRENT RESEARCH PROGRAMS
THE EXECUTIVE COMMITTEE
The Executive Committee is composed of four permanent Founding Directors and one At-large Director
U.S. Director:
Steve Cummings, M.D., FACP
Director of Clinical Research, California Pacific Medical Center Research Institute; Professor of Epidemiology, University of California, San Francisco.
cummings@cooper.cpmc.org
U.K. Director:
Mitch Dowsett
Professor Academic Department of Biochemistry, the Royal Marsden Hospital.
Mitch.Dowsett@icr.ac.uk
U.S. Co-Director:
Warren Browner, M.D., MPH
Vice-President, Academic Affairs; Scientific Director, California Pacific Medical Center Research Institute.
warren@cooper.cpmc.org
U.K. Co-Director:
Ian Smith, M.D., FRCP, FREPE
Professor of Cancer Medicine and Consultant Medical Oncologist, the Royal Marsden Hospital.
ian.smith@rmh.nthames.nhs.uk
At-large Director:
Leslie Bernstein, Ph.D.
Vice Provost for Medical Affairs, University of Southern California (USC) and Professor of Preventive Medicine, USC Keck School of Medicine and Norris Cancer Center.
lbern@usc.edu
THE DA COSTA ADVISORY BOARD
The Da Costa Advisory Board of seven members is chosen by the Executive Committee.
Current Advisory Board Members:
John F. Forbes
Professor of Surgical Oncology, University of Newcastle; Coordinator, ANZ BCTG; Director Department of Surgical Oncology, Newcastle Mater Hospital, Director of Breast Screen NSW.
john.forbes@anzbctg.newcastle.edu.au
Judy Garber, M.D. MPH
Director, Cancer Risk & Prevention, Breast Oncology Center, Dana-Farber Cancer Institute (DFCI); Associate Professor of Medicine, DFCI and Harvard Medical School.
Judy_Garber@dfci.harvard.edu
Susan E. Hankinson, Sc.D.
Associate Professor of Medicine at Harvard Medical School, Associate Professor of Epidemiology at the Harvard School of Public Health and Epidemiologist at the Brigham and Women’s Hospital.
sue.hankinson@channing.harvard.edu
Tony Howell, M.D.
Professor of Medical Oncology at the University of Manchester (Christie Hospital), Chairman of the European School of Oncology Breast Cancer Task Force (1994-present), Chairman of the MRC trial comparing mammography & MRI (MARIBS. 2000-present), Member of the North West Breast Group (1980-present).
anthony.howell@christie-tr.nwest.nhs.uk
Richard Santen, M.D.
Professor of Medicine. Associate Director of Clinical Research Cancer Center.
RJS5Y@hscmail.mcc.virginia.edu
CURRENT RESEARCH PROGRAMS
Proposing and approving funding
The Fund does not accept unsolicited applications for funding. The Directors, Advisory Board Members, will recommend that the Fund consider a project or person for support.
Eligibility for support from the fund will be limited to research that addresses the mission of the Fund. Proposals that include scientists at CPMCRI in the U.S. and/or at the Royal Marsden Hospital in the U.K. will be given priority. Priority given to research done locally.
If you have an idea for an interesting project, you may e-mail your idea to Alice LaRocca. After discussion by the Advisory Board, you may be asked to develop a proposal.